- Home
- TCRX vs ATLX Comparison
TCRX vs ATLX Comparison
Compare TCRX & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- ATLX
- Stock Information
- Founded
- TCRX 2018
- ATLX 2011
- Country
- TCRX United States
- ATLX Brazil
- Employees
- TCRX N/A
- ATLX N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- TCRX Health Care
- ATLX Industrials
- Exchange
- TCRX Nasdaq
- ATLX Nasdaq
- Market Cap
- TCRX 91.7M
- ATLX 95.1M
- IPO Year
- TCRX 2021
- ATLX N/A
- Fundamental
- Price
- TCRX $1.60
- ATLX $4.47
- Analyst Decision
- TCRX Strong Buy
- ATLX Strong Buy
- Analyst Count
- TCRX 5
- ATLX 1
- Target Price
- TCRX $9.40
- ATLX $19.00
- AVG Volume (30 Days)
- TCRX 219.1K
- ATLX 413.0K
- Earning Date
- TCRX 11-11-2025
- ATLX 11-07-2025
- Dividend Yield
- TCRX N/A
- ATLX N/A
- EPS Growth
- TCRX N/A
- ATLX N/A
- EPS
- TCRX N/A
- ATLX N/A
- Revenue
- TCRX $6,961,000.00
- ATLX $350,003.00
- Revenue This Year
- TCRX $255.18
- ATLX $22,084.55
- Revenue Next Year
- TCRX N/A
- ATLX N/A
- P/E Ratio
- TCRX N/A
- ATLX N/A
- Revenue Growth
- TCRX N/A
- ATLX N/A
- 52 Week Low
- TCRX $1.02
- ATLX $3.54
- 52 Week High
- TCRX $6.23
- ATLX $11.89
- Technical
- Relative Strength Index (RSI)
- TCRX 36.40
- ATLX 41.15
- Support Level
- TCRX $1.73
- ATLX $4.57
- Resistance Level
- TCRX $1.96
- ATLX $4.96
- Average True Range (ATR)
- TCRX 0.11
- ATLX 0.33
- MACD
- TCRX -0.03
- ATLX -0.08
- Stochastic Oscillator
- TCRX 0.00
- ATLX 2.80
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.